SBRA · Sabra Healthcare REIT Inc
United States · RS rating 68 · As of 2026-11-03
| Price | 20.35 USD |
|---|---|
| 1-day change | +3.2% |
| RS rating (overall / 1M / 3M / 12M) | 68 / 76 / 59 / 66 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 22 / 40 |
| Industry group (rank) | Finance-Property REIT (87) |
| EPS growth Q/Q | +22.2% |
| Sales growth Q/Q | +11.5% |
| Distance from 52-week high | +9.1% |
| Market cap (USD) | $5.0B |